Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Haslock

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
The Ulster Medical Journal|January 1, 1978
Osteoarthrosis: a bioengineering approach to aetiology and treatmentI Haslock
The Journal of Rheumatology. Supplement|February 1, 1990
Prevalence of NSAID-induced gastrointestinal morbidity and mortalityI Haslock
British Journal of Rheumatology|October 1, 1989
The ethics of placebo treatment in rheumatoid arthritis drug trialsI Haslock
Bailliere'S Clinical Rheumatology|December 1, 1987
The practising rheumatologist's viewI Haslock
Alimentary Pharmacology & Therapeutics|January 1, 1988
Should we use non-steroidal anti-inflammatory drugs?I Haslock
Hospital Medicine (London, England : 1998)|February 3, 2000
Introducing clinical governance in an acute trustI Haslock
British Journal of Rheumatology|May 1, 1992
Contracting in rheumatologyI Haslock
Current Medical Research and Opinion|January 1, 1975
The effect of alclofenac on clinical and laboratory measures of disease activity in rheumatoid arthritis: preliminary resultsI Haslock
British Medical Journal|April 13, 1974
Letter: Treatment of acute goutI Haslock
British Journal of Rheumatology|January 1, 1993
Arthritis and Rheumatism Council funding prioritiesI Haslock
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
The Ulster Medical Journal|January 1, 1978
Osteoarthrosis: a bioengineering approach to aetiology and treatmentI Haslock
The Journal of Rheumatology. Supplement|February 1, 1990
Prevalence of NSAID-induced gastrointestinal morbidity and mortalityI Haslock
British Journal of Rheumatology|October 1, 1989
The ethics of placebo treatment in rheumatoid arthritis drug trialsI Haslock
Bailliere'S Clinical Rheumatology|December 1, 1987
The practising rheumatologist's viewI Haslock
Alimentary Pharmacology & Therapeutics|January 1, 1988
Should we use non-steroidal anti-inflammatory drugs?I Haslock
Hospital Medicine (London, England : 1998)|February 3, 2000
Introducing clinical governance in an acute trustI Haslock
British Journal of Rheumatology|May 1, 1992
Contracting in rheumatologyI Haslock
Current Medical Research and Opinion|January 1, 1975
The effect of alclofenac on clinical and laboratory measures of disease activity in rheumatoid arthritis: preliminary resultsI Haslock
British Medical Journal|April 13, 1974
Letter: Treatment of acute goutI Haslock
British Journal of Rheumatology|January 1, 1993
Arthritis and Rheumatism Council funding prioritiesI Haslock
Pageof 11